BRADLEY PHARMACEUTICALS INC 4
4 · BRADLEY PHARMACEUTICALS INC · Filed Sep 15, 2003
Insider Transaction Report
Form 4
BHAGWAT DILEEP
VP - Research and Development
Transactions
- Discretionary Transaction
Stock Options (Right to buy)
2003-09-12$8.81/sh−1,877$16,536→ 0 totalExercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (1,877 underlying) - Sale
Common Stock
2003-09-10$28.40/sh−1,877$53,307→ 2,226 total - Discretionary Transaction
Common Stock
2003-09-10$8.81/sh+1,877$16,536→ 4,103 total
Holdings
- 753
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (753 underlying) - 1,000(indirect: By IRA)
Common Stock
- 1,501(indirect: By 401(k))
Common Stock
- 8,000
Stock Options (Right to buy)
Exercise: $1.09From: 2002-09-07Exp: 2009-09-06→ Common Stock (8,000 underlying)